Broadly, the study results showed that if a participant's cognitive ability, physical health, or mental health declined over the course of the 6-month study period, that participant became less cognitively engaged as the tasks increased in difficulty.
Pharmacies cannot prevent shortages, particularly with the complexities of treating COVID-19; however, they can strengthen their ability to prepare their organization to respond to those complexities.
The study found that more than 10% of participants who were previously infected with SARS-CoV-2 (seropositive) became reinfected, compared with new infections in 50% of participants who had not been previously infected (seronegative).
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
A new service connects community pharmacies with health care systems to support the delivery of health care products and services through crowdsourcing.
Face mask usage may help, and pharmacists can provide other education and guidance about safe and proper use of nonprescription medications.
Oncology experts recommend patients schedule overdue screenings, as pandemic restrictions ease.
This is the first systematic literature review on the association of back pain and mortality.
A CDC panel voted to add a warning label to the vaccine regarding rare cases of cerebral venous sinus thrombosis.
Loncastuximab tesirine-lpyl is a CD19-targeted antibody drug conjugate.
Pharmacists and other clinicians share responsibility for relieving symptoms, preventing transmission, and avoiding complications.
The POETYK PSO-1 and POETYK PSO-2 trials, which evaluated deucravacitinib 6 mg once daily, met both co-primary endpoints versus placebo, with significantly more patients achieving Psoriasis Area and Severity Index (PASI) 75 response and a static Physician's Global Assessment score of clear or almost clear (sPGA 0/1) after 16 weeks of treatment with deucravacitinib.
According to the study authors, the findings suggest a need for greater transparency in health care pricing as well as policies eliminating financial obstacles to catching cancer early.
Individuals who had COVID-19 and recovered had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose.
The study highlights a new role for pregnancy-associated plasma protein A, known as PAPPA, in gestational diabetes, with translational potential as both a diagnostic tool and therapeutic target.
Novel therapeutics under investigation include CAR T-cell therapies, antibody-drug conjugates, and bispecific antibodies, as well as other unique drugs.
New research findings published in Cell Reports identified a type of immune cells that acts as a major driver of breast cancer growth by preventing the accumulation of a specific protein that induces anti-tumor responses.
The decrease was lower in children under 2 years of age and recovered quickly in that group, but it remained persistent in older children.
B cell activating factor appears to promote antibodies against, and inhibitors of, the missing blood clotting factor that is given to patients with hemophilia A to control their bleeding.
During the Renaissance, a theory emerged in Europe regarding the source of human madness: a stone that was wedged deep inside the brain.
The legislation does not expand scope of practice, but instead brings Medicare rules in alignment with existing responsibilities already granted to pharmacists through various credentialing and privileging programs.
Physician expert witness excluded from testifying about standard of care in resulting lawsuit.
Tapping techs as immunizers opens up greater visibility and new source of health care labor.
People who used positive airway pressure therapy were less likely than others to receive a new diagnosis of dementia or mild cognitive impairment over the next 3 years.
Collaboration between a health coach and pharmacist is a relatively new concept, but initial evidence is promising.
The study further explored the various aspects of financial hardships, including material, psychological, and behavioral measures.
The risk peaks close to delivery and then improves by 1 year after delivery, though a modest risk of developing kidney stones continues beyond 1 year after delivery.
The researchers’ analysis was based on a large representative sample survey carried out in November to December 2020, which examined a range of factors that previous studies had found to be related to hesitancy about getting vaccinated against COVID-19.
The COVID-19 pandemic has created challenges and opportunities, and this requires agility and flexibility.
There have now been approximately 70,000 pregnant people vaccinated against COVID-19 with no evidence of harm.
